NOVADIP Biosciences S.A.

NOVADIP Biosciences S.A. is a pioneering biotechnology research company dedicated to transforming patient lives through its innovative “3M³” tissue regeneration technology platform. NOVADIP Biosciences S.A. is at the forefront of developing a new class of regenerative tissue products designed to accelerate the healing of large bone defects and injuries with a single, effective treatment. Located at Ru Granbonpré 11, Mont-Saint-Guibert, 1435, BE, NOVADIP Biosciences S.A. is committed to advancing medical science and improving patient outcomes.

NOVADIP Biosciences S.A.’s lead allogeneic product, NVD-X3, utilizes a matrix containing multiple bioactive factors that induce accelerated tissue healing. This “off-the-shelf” product boasts superior intraoperative handling characteristics and can be shipped and stored at room temperature, making it easily accessible and highly efficient. In addition to NVD-X3, NOVADIP Biosciences S.A. is also developing NVD-003, an autologous therapy derived from ASCs, which holds immense potential as a single treatment for patients with congenital pseudarthrosis of the tibia (CPT), a rare pediatric bone condition. NOVADIP Biosciences S.A. continues to push the boundaries of regenerative medicine.

With a focus on innovation and patient care, NOVADIP Biosciences S.A. is dedicated to addressing significant unmet medical needs in the field of tissue regeneration. The company’s commitment to research and development ensures that NOVADIP Biosciences S.A. remains a leader in biotechnology, striving to provide groundbreaking solutions that enhance the quality of life for patients worldwide. We invite the management of NOVADIP Biosciences S.A. to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional work.